0
     

Report Added
Report already added
Global In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Region: Trend Forecast and Growth Opportunity

Global In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Region: Trend Forecast and Growth Opportunity

Global in vitro diagnostics (IVD) market will reach $148,393.3 million by 2031, growing by 6.3% annually over 2021-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing.
Highlighted with 84 tables and 96 figures, this 194-page report “Global In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global in vitro diagnostics (IVD) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global in vitro diagnostics (IVD) market in every aspect of the classification from perspectives of Product, Technology, Sample Type, Application, End User, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Instruments & Devices
oDisposable IVD Devices
oReusable IVD Devices
•Reagents & Kits
•Software & Services

Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Clinical Chemistry
•Molecular Diagnostics
•Immuno Diagnostics
•Hematology
•Tissue Diagnostics
•Microbiology
•Coagulation and Hemostasis
•Urinalysis
•Other Technologies

By Sample Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Blood
•Mucus
•Urine
•Other Sample Types

By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Infectious Diseases
•Diabetes
•Cancer/Oncology
•Cardiology
•Autoimmune Disease
•Nephrology
•Drug Testing
•HIV/AIDS
•Other Applications

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Diagnostic Laboratories
•Hospitals and Clinics
•Homecare Settings
•Point-of-Care (POC) Settings
•Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
•North America (U.S., Canada, and Mexico)
•Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
•APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
•South America (Brazil, Chile, Argentina, Rest of South America)
•MEA (UAE,Saudi Arabia, South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product, Application and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Arkray Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
DiaSorin SpA (Luminex Corporation)
Epic Systems Corporation
F. Hoffmann-La Roche Ltd.
Genpact Limited
Grifols SA
IBM Corporation
Mckesson Corporation
Ortho Clinical Diagnostics Inc.
Qiagen NV
Quest Diagnostics Inc.
Quidel Corporation
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction10
1.1 Industry Definition and Research Scope10
1.1.1 Industry Definition10
1.1.2 Research Scope11
1.2 Research Methodology14
1.2.1 Overview of Market Research Methodology14
1.2.2 Market Assumption15
1.2.3 Secondary Data15
1.2.4 Primary Data15
1.2.5 Data Filtration and Model Design16
1.2.6 Market Size/Share Estimation17
1.2.7 Research Limitations18
1.3 Executive Summary19
2 Market Overview and Dynamics22
2.1 Market Size and Forecast22
2.1.1 Impact of COVID-19 on World Economy23
2.1.2 Impact of COVID-19 on the Market27
2.2 Major Growth Drivers29
2.3 Market Restraints and Challenges35
2.4 Emerging Opportunities and Market Trends38
2.5 Porter’s Fiver Forces Analysis42
3 Segmentation of Global Market by Product46
3.1 Market Overview by Product46
3.2 Instruments & Devices48
3.2.1 Disposable IVD Devices49
3.2.2 Reusable IVD Devices50
3.3 Reagents & Kits51
3.4 Software & Services52
4 Segmentation of Global Market by Technology53
4.1 Market Overview by Technology53
4.2 Clinical Chemistry55
4.3 Molecular Diagnostics56
4.4 Immuno Diagnostics57
4.5 Hematology58
4.6 Tissue Diagnostics59
4.7 Microbiology60
4.8 Coagulation and Hemostasis61
4.9 Urinalysis62
4.10 Other Technologies63
5 Segmentation of Global Market by Sample Type64
5.1 Market Overview by Sample Type64
5.2 Blood66
5.3 Mucus67
5.4 Urine68
5.5 Other Sample Types69
6 Segmentation of Global Market by Application70
6.1 Market Overview by Application70
6.2 Infectious Diseases72
6.3 Diabetes82
6.4 Cancer/Oncology83
6.5 Cardiology84
6.6 Autoimmune Disease85
6.7 Nephrology86
6.8 Drug Testing87
6.9 HIV/AIDS88
6.10 Other Applications89
7 Segmentation of Global Market by End User90
7.1 Market Overview by End User90
7.2 Diagnostic Laboratories92
7.3 Hospitals and Clinics93
7.4 Homecare Settings94
7.5 Point-of-Care (POC) Settings95
7.6 Other End Users96
8 Segmentation of Global Market by Region97
8.1 Geographic Market Overview 2021-203197
8.2 North America Market 2021-2031 by Country101
8.2.1 Overview of North America Market101
8.2.2 U.S.105
8.2.3 Canada108
8.2.4 Mexico110
8.3 European Market 2021-2031 by Country112
8.3.1 Overview of European Market112
8.3.2 Germany116
8.3.3 U.K.118
8.3.4 France120
8.3.5 Spain122
8.3.6 Italy124
8.3.7 Netherlands126
8.3.8 Rest of European Market128
8.4 Asia-Pacific Market 2021-2031 by Country130
8.4.1 Overview of Asia-Pacific Market130
8.4.2 Japan134
8.4.3 China137
8.4.4 Australia139
8.4.5 India141
8.4.6 South Korea143
8.4.7 Rest of APAC Region145
8.5 South America Market 2021-2031 by Country147
8.5.1 Argentina150
8.5.2 Brazil152
8.5.3 Chile154
8.5.4 Rest of South America Market156
8.6 MEA Market 2021-2031 by Country157
8.6.1 UAE160
8.6.2 Saudi Arabia162
8.6.3 South Africa164
8.6.4 Other National Markets166
9 Competitive Landscape167
9.1 Overview of Key Vendors167
9.2 New Product Launch, Partnership, Investment, and M&A170
9.3 Company Profiles171
Abbott Laboratories, Inc.171
Agilent Technologies, Inc.173
Arkray Inc.174
Becton, Dickinson and Company175
Biomerieux SA176
Bio-Rad Laboratories Inc.177
Danaher Corporation178
DiaSorin SpA (Luminex Corporation)179
Epic Systems Corporation180
F. Hoffmann-La Roche Ltd.181
Genpact Limited182
Grifols SA183
IBM Corporation184
Mckesson Corporation185
Ortho Clinical Diagnostics Inc.186
Qiagen NV187
Quest Diagnostics Inc.188
Quidel Corporation189
Roche Diagnostics190
Siemens Healthineers191
Sysmex Corporation192
Thermo Fisher Scientific Inc.193
RELATED REPORTS194List of Tables:

Table 1. Snapshot of Global In Vitro Diagnostics Market in Balanced Perspective, 2021-203120
Table 2. World Economic Outlook, 2021-203124
Table 3. World Economic Outlook, 2021-202325
Table 4. World Health Spending by Region, $ bn, 2013-202034
Table 5. Main Product Trends and Market Opportunities in Global In Vitro Diagnostics Market38
Table 6. Global In Vitro Diagnostics Market by Product, 2021-2031, $ mn46
Table 7. Global In Vitro Diagnostics Market: Instruments & Devices by Type, 2021-2031, $ mn48
Table 8. Global In Vitro Diagnostics Market by Technology, 2021-2031, $ mn53
Table 9. Global In Vitro Diagnostics Market by Sample Type, 2021-2031, $ mn64
Table 10. Global In Vitro Diagnostics Market by Application, 2021-2031, $ mn70
Table 11. Commercially Available COVID-19 Diagnostic Tests Approved in 2021-202273
Table 12. Global In Vitro Diagnostics Market by End User, 2021-2031, $ mn90
Table 13. Global In Vitro Diagnostics Market by Region, 2021-2031, $ mn98
Table 14. Leading National In Vitro Diagnostics Market, 2021 and 2031, $ mn100
Table 15. North America In Vitro Diagnostics Market by Country, 2021-2031, $ mn103
Table 16. U.S. In Vitro Diagnostics Market by Product, 2021-2031, $ mn107
Table 17. U.S. In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn107
Table 18. U.S. In Vitro Diagnostics Market by End User, 2021-2031, $ mn107
Table 19. Canada In Vitro Diagnostics Market by Product, 2021-2031, $ mn109
Table 20. Canada In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn109
Table 21. Canada In Vitro Diagnostics Market by End User, 2021-2031, $ mn109
Table 22. Mexico In Vitro Diagnostics Market by Product, 2021-2031, $ mn111
Table 23. Mexico In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn111
Table 24. Mexico In Vitro Diagnostics Market by End User, 2021-2031, $ mn111
Table 25. Europe In Vitro Diagnostics Market by Country, 2021-2031, $ mn115
Table 26. Germany In Vitro Diagnostics Market by Product, 2021-2031, $ mn117
Table 27. Germany In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn117
Table 28. Germany In Vitro Diagnostics Market by End User, 2021-2031, $ mn117
Table 29. U.K. In Vitro Diagnostics Market by Product, 2021-2031, $ mn119
Table 30. U.K. In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn119
Table 31. U.K. In Vitro Diagnostics Market by End User, 2021-2031, $ mn119
Table 32. France In Vitro Diagnostics Market by Product, 2021-2031, $ mn121
Table 33. France In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn121
Table 34. France In Vitro Diagnostics Market by End User, 2021-2031, $ mn121
Table 35. Spain In Vitro Diagnostics Market by Product, 2021-2031, $ mn123
Table 36. Spain In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn123
Table 37. Spain In Vitro Diagnostics Market by End User, 2021-2031, $ mn123
Table 38. Italy In Vitro Diagnostics Market by Product, 2021-2031, $ mn125
Table 39. Italy In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn125
Table 40. Italy In Vitro Diagnostics Market by End User, 2021-2031, $ mn125
Table 41. Netherlands In Vitro Diagnostics Market by Product, 2021-2031, $ mn127
Table 42. Netherlands In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn127
Table 43. Netherlands In Vitro Diagnostics Market by End User, 2021-2031, $ mn127
Table 44. In Vitro Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn129
Table 45. APAC In Vitro Diagnostics Market by Country, 2021-2031, $ mn132
Table 46. Japan In Vitro Diagnostics Market by Product, 2021-2031, $ mn136
Table 47. Japan In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn136
Table 48. Japan In Vitro Diagnostics Market by End User, 2021-2031, $ mn136
Table 49. China In Vitro Diagnostics Market by Product, 2021-2031, $ mn138
Table 50. China In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn138
Table 51. China In Vitro Diagnostics Market by End User, 2021-2031, $ mn138
Table 52. Australia In Vitro Diagnostics Market by Product, 2021-2031, $ mn140
Table 53. Australia In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn140
Table 54. Australia In Vitro Diagnostics Market by End User, 2021-2031, $ mn140
Table 55. India In Vitro Diagnostics Market by Product, 2021-2031, $ mn142
Table 56. India In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn142
Table 57. India In Vitro Diagnostics Market by End User, 2021-2031, $ mn142
Table 58. South Korea In Vitro Diagnostics Market by Product, 2021-2031, $ mn144
Table 59. South Korea In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn144
Table 60. South Korea In Vitro Diagnostics Market by End User, 2021-2031, $ mn144
Table 61. In Vitro Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn146
Table 62. South America In Vitro Diagnostics Market by Country, 2021-2031, $ mn149
Table 63. Argentina In Vitro Diagnostics Market by Product, 2021-2031, $ mn151
Table 64. Argentina In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn151
Table 65. Argentina In Vitro Diagnostics Market by End User, 2021-2031, $ mn151
Table 66. Brazil In Vitro Diagnostics Market by Product, 2021-2031, $ mn153
Table 67. Brazil In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn153
Table 68. Brazil In Vitro Diagnostics Market by End User, 2021-2031, $ mn153
Table 69. Chile In Vitro Diagnostics Market by Product, 2021-2031, $ mn155
Table 70. Chile In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn155
Table 71. Chile In Vitro Diagnostics Market by End User, 2021-2031, $ mn155
Table 72. MEA In Vitro Diagnostics Market by Country, 2021-2031, $ mn159
Table 73. UAE In Vitro Diagnostics Market by Product, 2021-2031, $ mn161
Table 74. UAE In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn161
Table 75. UAE In Vitro Diagnostics Market by End User, 2021-2031, $ mn161
Table 76. Saudi Arabia In Vitro Diagnostics Market by Product, 2021-2031, $ mn163
Table 77. Saudi Arabia In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn163
Table 78. Saudi Arabia In Vitro Diagnostics Market by End User, 2021-2031, $ mn163
Table 79. South Africa In Vitro Diagnostics Market by Product, 2021-2031, $ mn165
Table 80. South Africa In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn165
Table 81. South Africa In Vitro Diagnostics Market by End User, 2021-2031, $ mn165
Table 82. Abbott Laboratories, Inc.: Company Snapshot171
Table 83. Abbott Laboratories, Inc.: Business Segmentation172
Table 84. Abbott Laboratories, Inc.: Product Portfolio172

Report Title: Global In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Region: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM